恶性间皮瘤 malignant mesothelioma ; malignant mesothe ; peritonel mlignnt mesotheliom ; malignant peritoneal mesothelioma
和恶性间皮瘤 peritoneal malignant mesothelioma ; PMM ; peritonel mlignnt mesotheliom
胸膜恶性间皮瘤 malignant pleural mesothelioma
弥漫性恶性间皮瘤 pleural mesothelioma ; diffuse mesothelioma of pleura ; diffuse malignant mesothelioma
腹膜恶性间皮瘤 malignant peritoneal mesothelioma ; peritoneal malignant mesothelioma ; PMM ; MPM
间皮恶性间皮瘤 malignant mesothelioma
有关恶性间皮瘤 Peritoneal Mesothelioma
原代培养人恶性间皮瘤 Malignant PleuralMasothelioma ; MPM
恶性胸膜间皮瘤 MPM ; malignant pleural mesothelioma ; maglinent pheural mesothelioma ; malignant mesothelioma
恶性间皮细胞瘤 malignant mesothelioma
Conclusion Vimentin, MC, CR, TTF-1, CEA, Sp-B are ideal markers in distinguishing malignant mesothelioma from lung adenocarcinoma in the pleura by using immunohistochemical method.
结论用免疫组化方法鉴别胸膜恶性间皮瘤与转移性肺腺癌,波形蛋白、MC、CR、TTF-1、CEA、Sp-B是较为理想的标志物。
参考来源 - 免疫组化在胸膜上皮性恶性肿瘤鉴别诊断中的价值·2,447,543篇论文数据，部分数据来源于NoteExpress
腹腔恶性间皮瘤的结肠侵入。
目的：总结5例腹膜恶性间皮瘤的临床诊治经验。
Object:To summarize the clinical experience of diagnosis and treatment for 5 patients with malignant peritoneal mesothelioma.
用液基细胞学诊断恶性间皮瘤(MM)是有争议的。
The diagnosis of malignant mesothelioma (MM) in effusion specimens is controversial.
应用推荐